Zdrowie i gospodarka · 09/03/2012
FDA Releases Guidance on Norovirus Serological Reagents for Class II Devices
The FDA has made available a new guidance document outlining the requirements for norovirus serological reagents used in Class II medical devices, which must now comply with these special controls starting immediately.
Source: Federal Register — Food and Drug AdministrationOpen original release →